The most common types include hormone receptor-positive (HR+, estrogen and progesterone receptors), human epidermal growth factor receptor 2 positive (HER2-positive), and triple-negative breast cancer (TNBC), necessitating tailored therapeutic approaches. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.